Acquired MET D1228N Mutations Mediate Crizotinib Resistance in Lung Adenocarcinoma with ROS1 Fusion: A Case Report. Wang Y, Chen Z, Han X, Li J, et al. Oncologist 2021;26:178-181.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Chen Z, Han X, Li J, et al. Acquired MET D1228N Mutations Mediate Crizotinib Resistance in Lung Adenocarcinoma with ROS1 Fusion: A Case Report. Oncologist 2021;26:178-181.
PMID: 33000474